1
0
0
News
bims-almceb papers - Biomed NewsBiomed News
biomed.news
Rabea Mecklenbrauck, Michael Heuser. The introduction of new targeted therapies to the treatment algorithm of acute myeloid leukemia (AML) offers new ... › bims-almceb
SOHO Poster Award WinnersSociety of Hematologic Oncology
sohoonline.org
Rabea Mecklenbrauck, MD | Hannover Medical School, Hannover, Germany | AML-440: Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients.
LILRB3 Modulates Acute Myeloid Leukemia Progression ...X-MOL
newsletter.x-mol.com
— Rabea Mecklenbrauck, Michael Heuser · CD7-directed CAR T-cell therapy: a potential immunotherapy strategy for relapsed/refractory acute ...
Rabea Mecklenbrauck eine Musterschülerin - waz.de
www.waz.de
Žiniatinklis2012 m. rugs. 19 d., · Rabea Mecklenbrauck ist einer der 35 besten Abiturienten des Landes in diesem Jahr. Sie hat ihr Abitur mit der außergewöhnlichen Note 1,0 …
Netzwerk-Profile
LinkedIn: Rabea Mecklenbrauck – Essen und Umgebung, Deutschland ...
Rabea Mecklenbrauck. Student(in), WWU Münster. Essen und Umgebung, Deutschland2 Kontakte. Zum Vernetzen anmelden ...
LinkedIn: Rabea Mecklenbrauck - Newcastle University - Newcastle ...
View Rabea Mecklenbrauck's profile on LinkedIn, the world's largest professional community. Rabea's education is listed on their profile. See the complete ...
Rabea MecklenbrauckWeatherall Institute of Molecular Medicine
www.imm.ox.ac.uk
Rabea Mecklenbrauck - Postdoctoral Researcher.
Business-Profile
Rabea Mecklenbrauck University of Münster | WWUResearchGate
www.researchgate.net
Rabea Mecklenbrauck. University of Münster | WWU · Clinic for Internal Medicine A (Hematology, Hemostasis, Oncology and Pneumology).
Bücher
The Role of the Polycomb Group (PcG) Protein Complex in CDX2 ...Google
books.google.com
Rabea Mecklenbrauck. Westfälische Wilhelms-Universität Münster, Reviews. Reviews aren't verified, but Google checks for and removes fake content ... › about
Dokumente zum Namen
An Anti-CD33 Antibody−Calicheamicin Conjugate for ...ACS Publications
pubs.acs.org
von PR Hamann · · Zitiert von: 312 — Rabea Mecklenbrauck, Michael Heuser. Resistance to targeted therapies in acute myeloid leukemia. Clinical & Experimental Metastasis 2023,
65th ASH® Annual Meeting and ExpositionAmerican Society of Hematology
www.hematology.org
— Rabea Mecklenbrauck. Jose Mejias. Megan Melody. Max Mendez-Lopez. Ana Menezes. Gao Mengge. Leo Meriranta. Lauren Meyer. Xiaoli Mi. Mariia ...
ASH2023 abstracts: What's hot in AML?aml-hub.com
aml-hub.com
— Prognostic impact of clonality of myelodysplasia-related gene mutations in AML. Rabea Mecklenbrauck Monday, Dec :00–15:15. Influence ...
Agenda| Monday, 25 September HARMONY Allianceharmony-alliance.eu
www.harmony-alliance.eu
— ○ AML: Rabea Mecklenbrauck, Hannover Medical School | Projects: Identification of factors that can predict super- responders to ...
Wissenschaftliche Veröffentlichungen
AML-438 K ScienceDirect.comScienceDirect
www.sciencedirect.com
von R Chale · — Rabea Mecklenbrauck MD1, Nora Borchert RA1,. Piroska Klement MD1, Carolin Funke RA1,. Maximilian Brandes RA1, Louisa-Kristin Dallmann RA1,. › article › pii › pdf
Medizinische Hochschule Hannover : AG-Leukämieforschung - MHH
www.mhh.de
ŽiniatinklisDr. Rabea Mecklenbrauck. PhD Students Fiorella Charles Katrin Teich Jyoti Kandarp. Technische Mitarbeiter Kerstin Görlich Nadine Kattre Blerina Neziri …
AML-440 Prognosis of Molecularly-Defined Secondary ...ScienceDirect
www.sciencedirect.com
von R Mecklenbrauck · — AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients. Author links open overlay panel. Rabea Mecklenbrauck MD 1 , Nora Borchert ...
Real-World Analysis of Teclistamab in 115 RRMM Patients ...ScienceDirect
www.sciencedirect.com
von C Riedhammer · — , Theo Leitner MD 18 , Christoph Mann MD 19 , Rabea Mecklenbrauck 20 , Maximilian Merz MD 21 … Leo Rasche MD 26. Show more. Add to Mendeley.
Veröffentlichungen allgemein
Resistance to targeted therapies in acute myeloid leukemiaSpringer Link
link.springer.com
von R Mecklenbrauck · · Zitiert von: 3 — Rabea Mecklenbrauck & Michael Heuser. Authors. Rabea Mecklenbrauck. View author publications. You can also search for this author in PubMed ...
Poster: AML-440 Prognosis of Molecularly-Defined ...ResearchGate
www.researchgate.net
— Request PDF | On Oct 1, 2022, Rabea Mecklenbrauck and others published Poster: AML-440 Prognosis of Molecularly-Defined Secondary Acute ...
Rabea Mecklenbrauck - Deutsche Digitale Bibliothek
www.deutsche-digitale-bibliothek.de
ŽiniatinklisFormulieren Sie Ihre Suchanfrage genauer. Sie können festlegen, ob einer der Suchbegriffe, eine genaue Wortfolge oder alle Suchbegriffe in den Ergebnissen …
Sonstiges
LinkedIn · Ellen [P.B.] de WaalCa. 50 Reaktionen · vor 8 MonatenEllen [P.B.] de Waal on LinkedIn: #data #hematology #research #ash23 # ...
www.linkedin.com
... Rabea Mecklenbrauck, Hanover Medical School - Sjoerd Hermans, Erasmus MC - Alberto Hernandez, IBSAL_IIS Check all the HARMONY Alliance ...
Rabea Mecklenbrauck ( X)ORCID
orcid.org
— Rabea Mecklenbrauck. account_circle. Is this you? Sign in to start editing. Personal information. error No public information available. Record ...
Bestenehrung 2012, | Das Landesportal Land.NRW
www.land.nrw
ŽiniatinklisRabea Mecklenbrauck, Bönen. Ansprechpartner und Kontaktdaten der Pressestelle der Staatskanzlei für Journalistinnen und Journalisten
AML-440 Prognosis of Molecularly-Defined Secondary Acute ...Clinical Lymphoma Myeloma and Leukemia
www.clinical-lymphoma-myeloma-leukemia.com
von R Mecklenbrauck · — AML-440 Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients ; Rabea Mecklenbrauck, MD. Rabea Mecklenbrauck ; Nora Borchert, RA. Nora ... › ...
CLINICAL & EXPERIMENTAL METASTASIS - PeerefPeeref
www.peeref.com
Resistance to targeted therapies in acute myeloid leukemia: (2022) Rabea Mecklenbrauck, Michael Heuser. Check this box to post anonymously. › journals
TEILNEHMERINNEN - smims.nrw.de
www.smims.nrw.de
ŽiniatinklisRabea Mecklenbrauck Alexandra Brock Tharusan Thevathasan Carla Norwig Andreas Cüppers Stefan Kahnert Martin Rehbeck: Projektbeschreibung ...
Clin. Exp. Metastasis期刊最新论文 - X-MOLx-mol.com
m.x-mol.com
Clin. Exp. Metastasis (IF 4.51) Pub Date : Posted On : Rabea Mecklenbrauck, Michael Heuser. Portal vein tumor thrombosis in ... › paper
Clinical & Experimental Metastasis - Read by QxMDQxMD
read.qxmd.com
Rabea Mecklenbrauck, Michael Heuser. The introduction of new targeted therapies to the treatment algorithm of acute myeloid leukemia (AML) offers new ... › journal
Real-world practice patterns and barriers to quality care in acute mResearcher App
www.researcher-app.com
8 days ago. Resistance to targeted therapies in acute myeloid leukemia. Rabea Mecklenbrauck, Michael Heuser. Open access. Unbookmark paper Bookmark paper. › ...
Resistance to targeted therapies in acute myeloid leukemia.Europe PMC
europepmc.org
von R Mecklenbrauck · — Rabea Mecklenbrauck. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover Medical School, Carl-Neuberg-Str. › med
MHH Hämatologie AssistenzärzteMedizinische Hochschule Hannover
www.mhh.de
Rabea Mecklenbrauck (aktuell beurlaubt wegen Forschungsaufenthalt UK); Dr. Victoria Panagiota (Fachärztin/Funktionsoberärztin); Dr. Caroline Perner; Dr ...
October 2022Clinical Lymphoma Myeloma and Leukemia
www.clinical-lymphoma-myeloma-leukemia.com
Rabea Mecklenbrauck,; Nora Borchert,; Piroska Klement, ... Arnold Ganser,; Felicitas Thol,; Michael Heuser. Published in issue: October S251-S252. PDF ...
Resistance to targeted therapies in acute myeloid leukemiaNational Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von R Mecklenbrauck · Zitiert von: 3 — Authors. Rabea Mecklenbrauck , Michael Heuser. Affiliations. 1 Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation ...
Videos und PodcastsDeutsche Leukämie- und Lymphom-Hilfe
www.leukaemie-hilfe.de
Rabea Mecklenbrauck, Hannover (Bereitstellung seitens der Deutschen Leukämie- & Lymphom-Hilfe; Anmeldung auf der Internetseite der Tagungsschmiede erforderlich).
Prognostic Impact of Clonal Hierarchy of Myelodysplasia ...ASH Publications
ashpublications.org
— Prognostic Impact of Clonal Hierarchy of Myelodysplasia-Related Gene Mutations in AML Patients. Rabea Mecklenbrauck,. › article
Vyas Group: Biology and Treatment of Human Myeloid ...Weatherall Institute of Molecular Medicine
www.imm.ox.ac.uk
DPhil Student. Rabea Mecklenbrauck. Postdoctoral Researcher. Verena Korber. Postdoctoral Fellow. Selected publications. Article has an altmetric score of 42.
Myelodysplasia-Related Gene Mutations for NGS-Based MRD ...ashpublications.org
ashpublications.org
— Rabea Mecklenbrauck. Rabea Mecklenbrauck. 7Shared senior authorship, Hannover, Germany. 8Department of Hematology, Hemostasis, Oncology and ...
Prognostic Impact of Clonality of Myelodysplasia-Related ...ashpublications.org
ashpublications.org
— Prognostic Impact of Clonality of Myelodysplasia-Related Gene Mutations in AML. Rabea Mecklenbrauck, ... Rabea Mecklenbrauck et al., Blood,
Resistance to targeted therapies in acute myeloid leukemia ...X-MOL
www.x-mol.com
— Rabea Mecklenbrauck 1 , Michael Heuser 1. Affiliation. Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation Hannover ...
SOHO Announces Poster Award Winners at 10th Annual ...Blood Cancers Today
bloodcancerstoday.com
— “Prognosis of Molecularly-Defined Secondary Acute Myeloid Leukemia Patients.” First author: Rabea Mecklenbrauck, MD, of the Hannover Medical ...
Verwandte Suchanfragen zu Rabea Mecklenbrauck
| Nora Borchert Michael Heuser |
Personen Vorname "Rabea" (1357) Name "Mecklenbrauck" (40) |
sortiert nach Relevanz / Datum